Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258

BMC Cancer

Volumn 8, Issue , 2008, Pages

  Fork, Melani A M ^a   Escobar, Hugo Murua ^a,b   Soller, Jan T ^a,b   Sterenczak, Katharina A ^a,b   Willenbrock, Saskia ^a,b   Winkler, Susanne ^b   Dorsch, Martina ^c   Reimann Berg, Nicola ^a,b   Hedrich, Hans J ^c   Bullerdiek, Jörn ^a,b   Nolte, Ingo ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b UNIVERSITY OF BREMEN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENIC ACTIVITY; CELL STRAIN CT1258; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE TECHNIQUE; CYTOGENETICS; DISEASE MODEL; DOG; FEMALE; HISTOPATHOLOGY; IN VIVO CULTURE; INOCULATION; MALE; MOUSE; NONHUMAN; PROSTATE CARCINOMA; ANIMAL; CANCER TRANSPLANTATION; DOG DISEASE; MITOSIS INDEX; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DOG DISEASES; DOGS; FEMALE; MALE; MICE; MICE, INBRED NOD; MICE, SCID; MITOTIC INDEX; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 51249109496     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-8-240     Document Type: Article

References (20)

1. Waters DJ Sakr WA Hayden DW Lang CM McKinney L Murphy GP Radinsky R Ramoner R Richardson RC Tindall DJ Workgroup 4: Spontaneous prostate carcinoma in dogs and nonhuman primates Prostate 1998, 36:64-67. 10.1002/ (SICI)1097-0045(19980615)36:1<64::AID-PROS12>3.0.CO;2-G 9650919
2. Maini A Archer C Wang CY Haas GP Comparative pathology of benign prostatic hyperplasia and prostate cancer In Vivo 1997, 11(49):293-299. 9292295
3. Cornell KK Bostwick DG Cooley DM Hall G Harvey HJ Hendrick MJ Pauli BU Render JA Stoica G Sweet DC Waters DJ Clinical and pathological aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases Prostate 2000, 45:173-183. 10.1002/ 1097-0045(20001001)45:2<173::AID-PROS12>3.0.CO;2-R 11027417
4. Projections of global mortality and burden of disease from 2002 to 2030 http://www.who.int/healthinfo/statistics/bod_projections2030_paper.pdf
5. Fan TM de Lorimier LP Tumors of the male reproductive System Small Animal Clinical Oncology St. Louis, Saunders Withrow SJ, Vail DM 4 2007:637-648.
6. Obradovich J Walshaw R Goullaud E The influence of castration on the development of prostatic carcinoma in the dog: 43 cases (1978-1985) J Vet Intern Med 1987, 1(4):183-187. 3506104
7. Sorenmo KU Goldschmidt M Shofer F Goldkamp C Ferracone J Immunhistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time Vet Comp Oncol 2003, 1:48-56. 10.1046/j.1476-5829.2003.00007.x
8. Bell FW Klausner JS Hayden DW Feeney DA Johnston SD Clinical and pathological features of prostatic adenocarcinoma in sexual intact and castrated dogs: 31 cases (1970-1987) J Am Vet Med Assoc 1991, 199:1623-1630. 1778750
9. Leav I Schelling KH Adams JY Merk FB Alroy J Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth, and the ductal origin of carcinoma Prostate 2001, 48:210-224. 10.1002/pros.1100 11494337
10. Johnston SD Kamolpatana K Root-Kustritz MV Johnston GR Prostatic disorders in the dog Anim Reprod Sci 2001, 60-61:405-415. 10844211
11. LeRoy BE Thudi NK Nadella MV Toribio RE Tannehill-Gregg SH van Bokhoven A Davis D Corn S Rosol TJ New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft Prostate 2006, 66:1213-1222. 10.1002/pros.20408 16683269
12. L'Eplattenier HF Chen Li Lai van den Ham R Mol J van Sluijs F Teske E Regulation of COX-2 expression in canine prostate carcinoma: increased COX-2 expression is not related to inflammation JVIM 2007, 21:776-782. 10.1892/0891-6640(2007)21[776:ROCEIC]2.0.CO;2
13. Bell FW Klausner JS Hayden DW Lund EM Liebenstein BB Feeney DA Johnston SD Shivers JL Ewing CM Isaacs WB Evaluation of serum and seminal plasma markers in the diagnosis of canine prostatic disorders J Vet Intern Med 1995, 9(3):149-153. 7545754
14. Anidjar M Vilette JM Devauchelle P Delisle F Cotard JP Billotey C Cochand-Priollet B Copin H Barnoux M Triballeau S Rain JD Fiet J Teillac P Berthon P Cussenot O In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new prostate carcinoma cell line Prostate 2001, 46:2-10. 10.1002/ 1097-0045(200101)46:1<2::AID-PROS1002>3.0.CO;2-5 11170126
15. Winkler S Murua Escobar H Eberle N Reimann-Berg N Nolte I Bullerdiek J Establishment of a cell line derived from a canine prostate carcinoma with highly rearranged karyotype J Hered 2005, 96(7):782-785. 10.1093/ jhered/esi085 15994418
16. Murphy WJ Durum SK Anver MR Ferris DK McViar DW O'Shea JJ Ruscetti SK Smith MR Young HA Longo DL Induction of T cell differentiation and lymphomagenesis in the thymus of mice with severe combined immune deficiency (SCID) J Immunol 1994, 1;153(3):1004-14.
17. Prochazka M Gaskins HR Schultz LD Leiter EH The non obese diabetic Scid mouse: Model for spontaneous thymomagenesis associated with Immunodeficiency Proc Natl Acad Sci USA 1992, 89:3290-3294. 48852 1373493 10.1073/pnas.89.8.3290
18. Buhmeida A Pyrhönen S Laato M Collan Y Prognostic factors in prostate Cancer Diagn Pathol 2006, 1:4. 1479371 16759347 10.1186/ 1746-1596-1-4
19. Lage MJ Barber BL Harrison DJ Jun S The Cost of treating Skeletal- Related Events in Patients With Prostate Cancer Am J Manag Care 2008, 14(5):317-22. 18471035
20. http://www.who.int/infobase/report.aspx?rid=126